Stocks · Health care · Biological Products, (No Diagnostic Substances)

Editas Medicine, Inc.

EDIT Clue Score47
United States Fiscal year ends December CIK 0001650664 Results filed 5 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Gilmore Neil O'Neill
3 Sep 2026
CEO
Sold on a plan
5,124
$3.04
$15.56K
Amy Parison
3 Sep 2026
SVP, Chief Financial Officer
Sold on a plan
453
$3.04
$1.38K
Linda Burkly
3 Sep 2026
EVP, Chief Scientific Officer
Sold on a plan
709
$3.04
$2.15K
Amy Parison
3 Aug 2026
SVP, Chief Financial Officer
Sold on a plan
678
$2.58
$1.75K
Linda Burkly
28 Jul 2026
EVP, Chief Scientific Officer
Sold on a plan
4,928
$2.67
$13.16K
Linda Burkly
3 Jun 2026
EVP, Chief Scientific Officer
Sold on a plan
731
$2.70
$1.97K
Gilmore Neil O'Neill
3 Jun 2026
CEO
Sold on a plan
15,380
$2.70
$41.54K
Amy Parison
3 Jun 2026
SVP, Chief Financial Officer
Sold on a plan
464
$2.70
$1.25K
Linda Burkly
3 Mar 2026
EVP, Chief Scientific Officer
Sold on a plan
749
$2.02
$1.51K
Amy Parison
3 Mar 2026
SVP, Chief Financial Officer
Sold on a plan
474
$2.02
$957.48
Gilmore Neil O'Neill
3 Mar 2026
CEO
Sold on a plan
5,394
$2.02
$10.89K
Amy Parison
3 Dec 2025
SVP, Chief Financial Officer
Sold on a plan
461
$2.15
$992.58
Gilmore Neil O'Neill
3 Dec 2025
CEO
Sold on a plan
5,603
$2.15
$12.06K
Linda Burkly
3 Dec 2025
EVP, Chief Scientific Officer
Sold on a plan
713
$2.15
$1.54K
Gilmore Neil O'Neill
3 Sep 2025
CEO
Sold on a plan
5,592
$2.60
$14.52K
Amy Parison
3 Sep 2025
SVP, Chief Financial Officer
Sold on a plan
458
$2.60
$1.19K
Linda Burkly
3 Sep 2025
EVP, Chief Scientific Officer
Sold on a plan
710
$2.60
$1.84K
Amy Parison
7 Aug 2025
SVP, Chief Financial Officer
Sold on a plan
679
$2.58
$1.75K
Linda Burkly
31 Jul 2025
EVP, Chief Scientific Officer
Sold on a plan
5,121
$2.49
$12.76K
Gilmore Neil O'Neill
3 Jun 2025
CEO
Sold on a plan
15,192
$1.72
$26.20K
Linda Burkly
3 Jun 2025
EVP, Chief Scientific Officer
Sold on a plan
726
$1.72
$1.25K
Amy Parison
3 Jun 2025
SVP, Chief Financial Officer
Sold on a plan
446
$1.72
$768.90
Linda Burkly
4 Mar 2025
EVP, Chief Scientific Officer
Sold on a plan
2,891
$1.71
$4.95K
Gilmore Neil O'Neill
4 Mar 2025
CEO
Sold on a plan
16,632
$1.71
$28.45K
Erick Lucera
4 Mar 2025
EVP, Chief Financial Officer
Sold on a plan
4,109
$1.71
$7.03K
Baisong Mei
3 Dec 2024
EVP, Chief Medical Officer
Sold on a plan
541
$2.08
$1.12K
Gilmore Neil O'Neill
3 Dec 2024
CEO
Sold on a plan
1,618
$2.08
$3.36K
Gilmore Neil O'Neill
4 Sep 2024
CEO
Sold on a plan
1,555
$3.42
$5.33K
Baisong Mei
4 Sep 2024
EVP, Chief Medical Officer
Sold on a plan
518
$3.42
$1.77K
Linda Burkly
25 Jul 2024
EVP, Chief Scientific Officer
Sold on a plan
11,886
$5.42
$64.37K
Baisong Mei
19 Jul 2024
EVP, Chief Medical Officer
Sold on a plan
6,619
$5.21
$34.46K
Baisong Mei
4 Jun 2024
EVP, Chief Medical Officer
Sold on a plan
511
$5.50
$2.81K
Gilmore Neil O'Neill
4 Jun 2024
CEO
Sold on a plan
12,191
$5.50
$67.00K
Erick Lucera
20 May 2024
EVP, Chief Financial Officer
Sold on a plan
22,337
$5.61
$125.40K
Gilmore Neil O'Neill
5 Mar 2024
CEO
Sold on a plan
77,824
$9.42
$732.88K
Baisong Mei
4 Mar 2024
SVP, Chief Medical Officer
Sold on a plan
20,327
$9.42
$191.43K
Bruce Eaton
5 Dec 2023
EVP, Cbo and CTO
Sold on a plan
103
$10.90
$1.12K
Bruce Eaton
14 Nov 2023
EVP, Cbo and CTO
Sold on a plan
695
$8.21
$5.71K
Bruce Eaton
7 Nov 2023
EVP, Cbo and CTO
Sold on a plan
139
$8.40
$1.17K
Bruce Eaton
6 Sep 2023
EVP, Cbo and CTO
Sold on a plan
103
$8.82
$908.46
Bruce Eaton
11 Aug 2023
EVP, Cbo and CTO
Sold on a plan
702
$8.59
$6.03K
Bruce Eaton
8 Aug 2023
EVP, Cbo and CTO
Sold on a plan
141
$8.39
$1.18K
Baisong Mei
19 Jul 2023
SVP, Chief Medical Officer
Sold on a plan
4,317
$8.80
$37.99K
Bruce Eaton
5 Jun 2023
EVP, Cbo and CTO
Sold on a plan
105
$9.50
$997.82
Gilmore Neil O'Neill
5 Jun 2023
CEO
Sold on a plan
6,486
$9.50
$61.64K
Bruce Eaton
11 May 2023
EVP, Cbo and CTO
Sold on a plan
668
$9.87
$6.59K
Michelle Robertson
11 May 2023
EVP, Chief Financial Officer
Sold on a plan
949
$9.87
$9.37K
Bruce Eaton
9 May 2023
EVP, Cbo and CTO
Sold on a plan
135
$9.51
$1.28K

What was left out

Form 4 filings counted 275
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 48
Sales straight out of an exercise 63
Sales at will 106
Transactions with no price 0
Shares from compensation/vesting 1,580,660
Sales filed before the plan box existed 106
History held since 4 Feb 2016